Exploiting tumor aneuploidy as a biomarker and therapeutic target in patients treated with immune checkpoint blockade

Spurr, Liam F.; Pitroda, Sean P.

doi:10.6082/cgwr4-q9v11

Published January 2, 2024 | Version v1

Journal article Open

Exploiting tumor aneuploidy as a biomarker and therapeutic target in patients treated with immune checkpoint blockade

1. University of Chicago

Files

Exploiting-tumor-aneuploidy-as-a-biomarker-and-therapeutic-target.pdf

Files (619.6 kB)

Name	Size	Download all
Exploiting-tumor-aneuploidy-as-a-biomarker-and-therapeutic-target.pdf md5:941e7889e3374be3dd9f426902e20f16	619.6 kB	Preview Download

Additional details

DOI: 10.1038/s41698-023-00492-8
Other: oai:uchicago.tind.io:10275

Ludwig Cancer Research Foundation
LUNGevity Foundation
Career Development Award
University of Chicago
Ullman Scholarship in Translational Cancer Immunology from the Comprehensive Cancer Center
University of Chicago
Cancer Spotlight Grant from the Comprehensive Cancer Center
United-4 A Cure Foundation
Fight Against Cancer Grant

Division(s): Biological Sciences Division, Pritzker School of Medicine
Department(s): Radiation and Cellular Oncology
Center(s) or Institute(s): Ludwig Center for Metastasis Research

Views

Downloads

Show more details

	All versions	This version
Views	0	0
Downloads	0	0
Data volume	0 Bytes	0 Bytes

More info on how stats are collected....

DOI

Resource type

Journal article

Publisher

University of Chicago

Published in

npj Precision Oncology, 2024.

Languages

English

License

Creative Commons Attribution 4.0 International

The Creative Commons Attribution license allows re-distribution and re-use of a licensed work on the condition that the creator is appropriately credited. Read more
Distribution License

No further description.

Copyrights

© The Author(s) 2024 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Technical metadata

Created: May 22, 2026
Modified: May 22, 2026

Exploiting tumor aneuploidy as a biomarker and therapeutic target in patients treated with immune checkpoint blockade

Files

Exploiting-tumor-aneuploidy-as-a-biomarker-and-therapeutic-target.pdf

Files (619.6 kB)

Additional details

Identifiers

Funding

UChicago Information

Exploiting tumor aneuploidy as a biomarker and therapeutic target in patients treated with immune checkpoint blockade

Creators

Files

Exploiting-tumor-aneuploidy-as-a-biomarker-and-therapeutic-target.pdf

Files (619.6 kB)

Additional details

Identifiers

Funding

UChicago Information